Back to Journals » Clinical Ophthalmology » Volume 4

Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide

Authors Yuki K, Inoue M, Shiba D, Kawamura R, Ishida S, Ohtake Y

Published 31 March 2010 Volume 2010:4 Pages 247—249

DOI https://doi.org/10.2147/OPTH.S9318

Review by Single anonymous peer review

Peer reviewer comments 1



Kenya Yuki1, Makoto Inoue1,2, Daisuke Shiba1, Ryosuke Kawamura1, Susumu Ishida1, Yuichiro Ohtake1

1Department of Ophthalmology, Keio University School of Medicine, 2Kyorin Eye Center, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

Purpose: To report on the efficacy of selective laser trabeculoplasty (SLT) for elevated intraocular pressure (IOP) following subtenon injection of triamcinolone acetonide.

Method: SLT was performed on four of 148 eyes in which IOP was elevated after a subtenon injection of triamcinolone acetonide and could not be maintained within normal limits by conventional medications. Postoperative IOP and relative reduction of IOP were evaluated.

Results: IOP was reduced in three eyes to within the normal range without any medications six months after SLT alone, but trabeculotomy was performed on one eye. Percentage reduction in IOP after SLT was 21.6% at one month, 45.0% at three months, and 52.7% at nine months.

Conclusion: SLT may be effective in reducing elevated IOP following subtenon injection of triamcinolone acetonide and should be considered before glaucoma surgery.

Keywords: selective laser trabeculoplasty, steroid glaucoma, subtenon injection, triamcinolone acetonide

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.